powered by LeadingAge New York

State Continues Medicaid Reimbursement Policy for COVID-19 Vaccine Post-State PHE

This past weekend, the Department of Health (DOH) issued State Medicaid Coverage Policy and Billing Guidance for the Administration of COVID-19 Vaccines Authorized for Emergency Use carrying forth provisions allowing this practice post-state public health emergency (PHE). The guidance provides instructions for providers to bill the cost of administration of authorized COVID-19 vaccine.

As announced in Executive Order (EO) 210, the state PHE ended effective June 25, 2021. New York Medicaid’s policy for the administration of COVID-19 vaccine will continue to remain in effect in accordance with the federal Public Readiness and Emergency Preparedness Act (PREP Act). As additional COVID-19 vaccines become available under an emergency use authorization (EUA) or are otherwise approved by the Food and Drug Administration (FDA), the billing guidance will be updated as needed.

As members know, the many Medicaid telehealth flexibilities granted during the state PHE were also extended through the end of the federal PHE. A recent DOH Medicaid Update providing more details is available here.

Contact: Meg Everett, meverett@leadingageny.org, 518-929-9342